Exotic Tumor Database.

Diagnoses of cancer are increasing in frequency in exotic animal medicine and zoological institutions. Increasingly, there are parallels between human and animal cancer and therapeutics. Further, improved preventive medicine and earlier diagnoses of cancer in exotic and zoological species has expanded the therapeutic options in these animals. Cancers have been diagnosed and treated in fish, reptiles, birds, and all forms of mammals. Reported cancers include lymphomas, papillomas, carcinomas, sarcomas, and melanomas. There are likely to be many more cases that have gone unreported, whether as case reports or case series. Treatments in zoo and exotic animals have been facilitated by use of vascular access ports for delivery of chemotherapy, anesthesia for radiation treatments, operant conditioning and the development of newer, safer medications. The Exotic Species Cancer Research Alliance, in collaboration with Stanford University, North Carolina State University, and U.C. Davis is developing a database for clinicians in private practice and in zoological institutions to contribute cases, and be able to query for parameters related to tumor type, treatment types, adverse effects of treatment and outcomes once there are enough cases in the database. Institutions are encouraged to participate through case contributions to this database, which will include diagnoses, plus annotation of any therapeutics employed and outcomes observed. Through these collaborative efforts, we hope to discover trends in cancer incidence, better understand treatment and therapeutic options for exotic and zoological species, and provide a long-term archive of study material for future research.

Study Design:
Retrospective Survey, will also accept prospective cases as they develop while the database is collecting cases.

Inclusion Criteria:

• Histologically confirmed neoplasia in non-domestic or zoological species. Cases do not have to be treated to be included.
• Cases should have an initial date of presentation for the cancer as well as a date of death or a date of last follow-up that is at least 6 months following the last treatment (if provided).
• Cases with full necropsy are preferred, but full necropsy is not required for case inclusion.

Exclusion Criteria:

• Tumors without histological confirmation or cases lost to follow-up less than six months following the last treatment.

Samples:
Survey link for data submission:
https://redcap.stanford.edu/surveys/?s=9K9R49WREW

Files for Download:
Data should be submitted using this link:
https://redcap.stanford.edu/surveys/?s=9K9R49WREW

Please note: Clinician are welcome to enter their own cases, but we recognize that this is often not feasible. We have resources available to help with case entry if this is an issue. Please contact the investigators for assistance in entering cases into the database.

Costs/Reimbursements:
None

Full Disclosure information:
The study is funded by a grant from Stanford University.
Redcap at Stanford is supported by grant support from NIH/NCRR: UL1 TR001085

The investigator does not have a conflict of interest.